Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis

This study has been completed.

Study NCT00548574 Information provided by Shire Pharmaceutical Development

First Received: October 23, 2007 Last Updated: May 5, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2005
Estimated Primary Completion Date:	No date given